Immuneed
Linking pre-clinical data to reality
- CEO: Camilla Oldgren
- First investment year: 2016
- Fund: Eastern Mid Sweden
- Business sector: Life Science

.
Immuneed is a life science biotech company offering a lab-based human whole-blood assay as a specialized service, for detection of immune-related side effects of biopharmaceuticals. The assay can minimize risks related to drug infusion reactions as well as decrease cost for pre-clinical drug development; linking preclinical data to clinical reality.